BQGE:F:F-Ossiam Lux Barclays Quantic Global E NR (EUR)

ETF | Others |

Last Closing

USD 115.4

Change

-0.64 (-0.55)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-01 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

+0.08 (+0.30%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.89 (+1.76%)

USD 117.56B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.15 (+0.28%)

USD 97.02B
SXR8:F iShares Core S&P 500 UCITS ETF..

+0.62 (+0.11%)

USD 89.53B
EUNL:F iShares Core MSCI World UCITS ..

N/A

USD 72.04B
FRCJ:F UBS MSCI Japan Socially Respon..

+0.07 (+0.32%)

USD 71.25B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.05 (+0.30%)

USD 58.22B
SXRZ:F iShares VII PLC - iShares Nikk..

N/A

USD 56.96B
VUAA:F Vanguard S&P 500 UCITS Acc

N/A

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

+0.22 (+0.23%)

USD 51.63B

ETFs Containing BQGE:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.05% 43% F 55% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.05% 40% F 48% F
Trailing 12 Months  
Capital Gain 11.54% 59% D- 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.54% 56% F 57% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 4.96% 60% D- 61% D-
Dividend Return 4.96% 58% F 55% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 7.08% 76% C+ 92% A
Risk Adjusted Return 70.13% 88% B+ 90% A-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:

There is nothing we particularly dislike